Multiple Sclerosis: An Update.

Update on riboflavin and multiple sclerosis: a systematic review

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an important role in myelin formation, and its deficiency is implicated as a risk factor for multiple sclerosis. Here, we systematically reviewed the literature concerning the health benefits of riboflavin on MS. The literature recorded within four main databases, including rel...

P138: Effect of Exercise on Improvement of Patients with Multiple Sclerosis

Multiple Sclerosis (MS) is a prevalent neurological and non-traumatic disease which is most common in young and adult women. Multiple Sclerosis is a disabling disease can affect various aspects of life. Studies have reported that complement and alternative treatments can have positive effects on people with MS. Exercise presents an important behavioral approach for counteracting the declines in...

Update on the international project on pathologic correlates in MS.

Current trends in multiple sclerosis research: an update on pathogenic concepts.

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) of presumed autoimmune origin which develops in a genetic susceptible individual triggered by additional environmental factors. In this review we will provide an update of basic pathogenic concepts. In addition, we will discuss newly evolving concepts in MS pathogenesis such as pathogenic heterogeneity...

AANA Journal course: update for nurse anesthetists--an overview of multiple sclerosis and implications for anesthesia.

Multiple sclerosis is the most common demyelinating, chronic disease of the central nervous system diagnosed in and affecting young adults. This disease can significantly alter the life of affected people, and there is no known cure. It is important to understand and review this disease process because anesthesia providers are likely to encounter patients with multiple sclerosis in their practi...

Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis

Introduction: Multiple sclerosis (MS) is a lifelong disease of the brain and spinal cord. Fingolimod is an oral drug which modulates the S1P receptor and is used for relapsing remitting form of MS and can causes rebound activity if it is ceased even in a short period of washout time.   Case Report: Here, we introduce a young girl, a known case of MS, who developed revers...